Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis

Background: Hemodialysis patients are at an increased risk of SARS-CoV-2 infection and are excluded from preauthorization COVID-19 vaccine trials; therefore, their immunogenicity is uncertain. Methods: To compare the antibody responses to homologous ChAdOx1 and mRNA-1273 SARS-CoV-2 vaccination in he...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Shih-Hsin, Sue, Yuh-Mou, Kao, Chih-Chin, Chang, Hui-Wen, Lin, Yen-Chung, Hung, Ching-Sheng, Hsieh, Yi-Chen, Hong, Shiao-Ya, Chung, Chi-Li, Chang, Jer-Hwa, Su, Ying-Shih, Liu, Ming-Che, Lai, Kevin Shu-Leung, Chien, Ko-Ling, Wang, Jude Chu-Chun, Cheng, Chung-Yi, Fang, Te-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383458/
https://www.ncbi.nlm.nih.gov/pubmed/37514977
http://dx.doi.org/10.3390/vaccines11071161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383458/
https://www.ncbi.nlm.nih.gov/pubmed/37514977
http://dx.doi.org/10.3390/vaccines11071161

Ejemplares similares